Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Epaud

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
European Journal of Pediatrics|June 9, 2022
French national cohort of neuroendocrine cell hyperplasia of infancy (FRENCHI) study: diagnosis and initial managementCandice Fabre, Caroline Thumerelle, Morgane Dervaux, et al.
Respiratory Medicine|July 23, 2017
Heterogeneity of lung disease associated with NK2 homeobox 1 mutationsElodie Nattes, Stephanie Lejeune, Ania Carsin, et al.
Human Molecular Genetics|November 10, 2011
Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in childrenFlorence Flamein, Laure Riffault, Céline Muselet-Charlier, et al.
Orphanet Journal of Rare Diseases|December 5, 2019
Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosisRaphael Borie, Caroline Kannengiesser, Laurent Gouya, et al.
Orphanet Journal of Rare Diseases|April 22, 2018
Pulmonary hemosiderosis in children with Down syndrome: a national experienceAurelia Alimi, Jessica Taytard, Rola Abou Taam, et al.
American Journal of Respiratory and Critical Care Medicine|July 7, 2020
Targeting p16<sup>INK4a</sup> Promotes Lipofibroblasts and Alveolar Regeneration after Early-Life InjuryMaéva Zysman, Bruno Ribeiro Baptista, Laure-Aléa Essari, et al.
Clinical Pharmacokinetics|February 4, 2024
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyNaïm Bouazza, Saïk Urien, Frantz Foissac, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 27, 2012
Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 geneDomitille Gras, Laurence Jonard, Emmanuel Roze, et al.
Orphanet Journal of Rare Diseases|February 5, 2010
Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009Sébastien Héritier, Martine Le Merrer, Francis Jaubert, et al.
Orphanet Journal of Rare Diseases|September 10, 2020
Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort studySolenne Le Louet, Mohamed-Aziz Barkaoui, Jean Miron, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
European Journal of Pediatrics|June 9, 2022
French national cohort of neuroendocrine cell hyperplasia of infancy (FRENCHI) study: diagnosis and initial managementCandice Fabre, Caroline Thumerelle, Morgane Dervaux, et al.
Respiratory Medicine|July 23, 2017
Heterogeneity of lung disease associated with NK2 homeobox 1 mutationsElodie Nattes, Stephanie Lejeune, Ania Carsin, et al.
Human Molecular Genetics|November 10, 2011
Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in childrenFlorence Flamein, Laure Riffault, Céline Muselet-Charlier, et al.
Orphanet Journal of Rare Diseases|December 5, 2019
Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosisRaphael Borie, Caroline Kannengiesser, Laurent Gouya, et al.
Orphanet Journal of Rare Diseases|April 22, 2018
Pulmonary hemosiderosis in children with Down syndrome: a national experienceAurelia Alimi, Jessica Taytard, Rola Abou Taam, et al.
American Journal of Respiratory and Critical Care Medicine|July 7, 2020
Targeting p16<sup>INK4a</sup> Promotes Lipofibroblasts and Alveolar Regeneration after Early-Life InjuryMaéva Zysman, Bruno Ribeiro Baptista, Laure-Aléa Essari, et al.
Clinical Pharmacokinetics|February 4, 2024
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyNaïm Bouazza, Saïk Urien, Frantz Foissac, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 27, 2012
Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 geneDomitille Gras, Laurence Jonard, Emmanuel Roze, et al.
Orphanet Journal of Rare Diseases|February 5, 2010
Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009Sébastien Héritier, Martine Le Merrer, Francis Jaubert, et al.
Orphanet Journal of Rare Diseases|September 10, 2020
Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort studySolenne Le Louet, Mohamed-Aziz Barkaoui, Jean Miron, et al.
Pageof 12